Sulfinpyrazone
(MBGGBVCUIVRRBF-UHFFFAOYSA-N)
Structure
- SMILES
- O=C1N(c2ccccc2)N(C(=O)C1CCS(=O)c1ccccc1)c1ccccc1
- Type(s)
- Approved
- ATC code(s)
- M04AB02
- Molecular Formula:
- C23H20N2O3S
- Molecular Weight:
- 404.482
- Log P:
- 4.7912
- Hydrogen Bond Acceptor:
- 5
- Hydrogen Bond Donor:
- 0
- TPSA:
- 76.9
- CAS Number(s):
- 57-96-5
Synonym(s)
1.
Sulfinpyrazone
2.
Sulfoxyphenylpyrazolidin
3.
Anturan
4.
Anturane
5.
Apo-Sulfinpyrazone
6.
Nu-Sulfinpyrazone
7.
Sulphinpyrazone
8.
Apo Sulfinpyrazone
9.
Nu Sulfinpyrazone
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Abdominal Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 2 | Acute kidney injury | Canada Vigilance: 2 | CTD Canada Vigilance | |
| 3 | Angina Pectoris | 6665767 | CTD | |
| 4 | Anuria | Canada Vigilance: 1 | Canada Vigilance | |
| 5 | Arthritis, Gouty | 9587090 | CTD | |
| 6 | Blood alkaline phosphatase increased | Canada Vigilance: 1 | Canada Vigilance | |
| 7 | Brain Ischemia | 795299 | CTD | |
| 8 | Dermatitis | Canada Vigilance: 1 | Canada Vigilance | |
| 9 | Dizziness | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | Eczema | Canada Vigilance: 1 | Canada Vigilance | |
| 11 | Gout | 1064465 6781590 | CTD | |
| 12 | Headache | Canada Vigilance: 1 | Canada Vigilance | |
| 13 | Hyperuricemia | 9587090 | CTD | |
| 14 | Kidney Diseases | CTD | ||
| 15 | Multiple Myeloma | 1064465 | CTD | |
| 16 | Myocardial Infarction | 6272002 | CTD | |
| 17 | Nausea | Canada Vigilance: 1 | Canada Vigilance | |
| 18 | Nephritis, Interstitial | 3157154 6234742 7258104 | CTD | |
| 19 | Nephrolithiasis | Canada Vigilance: 1 | Canada Vigilance | |
| 20 | Pharyngitis | Canada Vigilance: 1 | Canada Vigilance | |
| 21 | Pruritus | Canada Vigilance: 1 | Canada Vigilance | |
| 22 | Purpura | Canada Vigilance: 1 | Canada Vigilance | |
| 23 | Rash erythematous | Canada Vigilance: 1 | Canada Vigilance | |
| 24 | Renal Insufficiency | 962450 7084072 | CTD | |
| 25 | Thrombocytopenia | Canada Vigilance: 1 | Canada Vigilance | |
| 26 | Urolithiasis | 7249646 | CTD | |
| 27 | Vertigo | Canada Vigilance: 2 | Canada Vigilance | |
| 28 | Visual Impairment | Canada Vigilance: 1 | Canada Vigilance | |
| 29 | Vomiting | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.